These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 21400918

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS.
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Treatment of neovascular age-related macular degeneration with intravitreal vascular endothelial growth factor inhibitor--secondary publication].
    Larsen M, Sander B, Villumsen JE, Haamann PH, la Cour M, Lund-Andersen H, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group.
    Ugeskr Laeger; 2005 Aug 29; 167(35):3301-5. PubMed ID: 16138974
    [Abstract] [Full Text] [Related]

  • 28. Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.
    Bennett MD, Yee W, Bryan JS.
    Retina; 2008 Aug 29; 28(7):976-80. PubMed ID: 18698300
    [Abstract] [Full Text] [Related]

  • 29. Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study.
    Weber PA, Wirostko BM, Xu X, Goss TF, Zlateva G.
    BMC Ophthalmol; 2010 Feb 09; 10():2. PubMed ID: 20144224
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pegaptanib for wet macular degeneration.
    Fraunfelder FW.
    Drugs Today (Barc); 2005 Nov 09; 41(11):703-9. PubMed ID: 16395411
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration.
    Calvo-González C, Reche-Frutos J, Donate-López J, García-Feijoó J, Leila M, Fernández-Pérez C, Garcia-Sánchez J.
    Br J Ophthalmol; 2008 Jan 09; 92(1):74-5. PubMed ID: 18156376
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Avila MP, Farah ME, Santos A, Carla L, Fuji G, Rossi J, Nau J.
    Retina; 2012 Jan 09; 32(1):10-8. PubMed ID: 21817963
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.